20 Sep 2017 | 7:55 AM
 

Divi`s Laboratories Ltd. Share Price Live (BSE)
1

BSE Code: 532488 | NSE Symbol: DIVISLAB
863.85
30.10
(3.62 %)
19 Sep 2017 | 03:58 PM
Change company
  • Open (Rs)
    843.90
  • Prev. close (Rs.)
    833.75
  • High (Rs.)
    872.45
  • Low (Rs.)
    801.70
  • 52W H (Rs.)
    1,355.45
  • 52W L (Rs.)
    533.10
  • Volume (Rs.)
    1006129
  • MCap (Rs in Cr.)
    22,932.54
863.25
25.80
(3.08 %)
  • Open (Rs)
    842.05
  • High (Rs)
    877.00
  • Low (Rs)
    805.05
  • Prev. close(Rs)
    837.45
  • Contracts Tra.
    2,09,50,400
  • Turnover (Cr.)
    1,792
  • Open Interest
    98,73,600
  • Open Int. chg
    97,20,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
39.95
Operating Margin (%)
35.57
Gross Profit Margin (%)
32.54
Net Profit Margin (%)
26.09
Total Debt/Equity
0.01
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

14 Sep 2017 - 12:09:00-Shares of Divi's Laboratories continued gaining momentum for the fifth straight session and soar...
14 Aug 2017 - 11:47:00-Divi's Laboratories has received environment clearance for modernisation of its bulk drug unit i...
14 Aug 2017 - 11:47:00-Divi's Laboratories has received environment clearance for modernisation of its bulk drug unit i...
04 Aug 2017 - 15:51:00-Drug firm Divi's Laboratories today said its Vishakhapatnam facility has successfully completed ...

Announcements

30-Aug-2017
Divi`s Lab - Updates
30-Aug-2017
Divi`s Lab - Updates
22-Aug-2017
Divi`s Lab - Fixes Book Closure for Dividend & AGM
21-Aug-2017
Divi`s Lab - AGM/Book Closure
21-Aug-2017
Divi`s Lab - Fixes Book Closure For Annual General Meeting And Dividend

Religare Research

20 Sep 2017 | 07:00 AM
Markets are at record high and cues from the global front are still mixed. In such scenario, it’s pr...
19 Sep 2017 | 10:00 AM
The Indian rupee fell to a four-week low against the dollar, as state-run lenders bought the greenba...
19 Sep 2017 | 09:17 AM
• Gold dipped as equities and dollar surged ahead of Fed meeting • Oil prices steadied, held near re...
19 Sep 2017 | 07:00 AM
We suggest refraining from aggressive positions amid mixed signals and preferring hedged positions u...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
24,33,441 575.29 88.83 0.44
24,33,441 575.29 32.74 0.44
24,33,441 575.29 88.83 0.44
24,33,441 575.29 21.95 0.70
24,33,441 575.29 92.07 0.44

Shareholding Pattern

       
Promotors52.07%
Mutual Funds/UTI13.75%
FI/Banks0.45%
Insurance0.45%
FII17.22%
Government0.00%
Others6.72%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,775.00(-2.40)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,410.00(0.02)
3317
 Dr. Reddy`s Laboratories Ltd.
2,239.10(-0.25)
3294
 Alkem Laboratories Ltd.
1,779.20(-1.25)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Divi`s Laboratories Ltd.241.40218.5573.15
NIFTY(S&P CNX)393.20490.001,020.70
BSE SENSEX1,143.521,090.802,883.63
BSE 500715.36823.111,670.43

Corporate Details

Key Personal
Kiran S Divi
President & Director
Madhusudana Rao Divi
Director - Projects
Murali K Divi
Chairman & Managing Director
Key Address
Registered Office
1-72/23(P)/DIVIS/303 Divi Towers Cyber Hills Gachibowli,Hyderabad,Telangana

Tel:040-23786300, Fax:040-23786460

mail@divislaboratories.com
http://www.divislaboratories.com
Registrar Office
In House

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Divi`s Laboratories Ltd. that will help you decide whether to buy, sell or hold Divi`s Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Divi`s Laboratories Ltd.